These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20948291)

  • 1. Antibody immunosuppressive therapy in solid organ transplant: Part II.
    Klipa D; Mahmud N; Ahsan N
    MAbs; 2010; 2(6):607-12. PubMed ID: 20948291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal antibodies in organ transplantation].
    Vanhove B
    Med Sci (Paris); 2009 Dec; 25(12):1121-5. PubMed ID: 20035690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of immunosuppressive agents for solid organ transplantation in children.
    Coelho T; Tredger M; Dhawan A
    Pediatr Transplant; 2012 Mar; 16(2):106-22. PubMed ID: 22360399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
    Wilde MI; Goa KL
    Drugs; 1996 May; 51(5):865-94. PubMed ID: 8861551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of basiliximab in solid organ transplantation.
    Henry ML; Rajab A
    Expert Opin Pharmacother; 2002 Nov; 3(11):1657-63. PubMed ID: 12437498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy: why, when, and which agent?
    Krischock L; Marks SD
    Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daclizumab: a review of its use in the management of organ transplantation.
    Carswell CI; Plosker GL; Wagstaff AJ
    BioDrugs; 2001; 15(11):745-73. PubMed ID: 11707149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
    Swiatecka-Urban A
    Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM; Keating GM
    Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.
    Waid TH; Lucas BA; Thompson JS; McKeown JW; Brown S; Kryscio R; Skeeters LJ
    Transplantation; 1997 Jul; 64(2):274-81. PubMed ID: 9256187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity in solid organ transplantation: an update and therapeutic opportunities.
    Béland S; Désy O; Vallin P; Basoni C; De Serres SA
    Expert Rev Clin Immunol; 2015 Mar; 11(3):377-89. PubMed ID: 25644774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptors.
    Alegre ML; Lenschow DJ; Bluestone JA
    Dig Dis Sci; 1995 Jan; 40(1):58-64. PubMed ID: 7821120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muromonab CD3. A review of its pharmacology and therapeutic potential.
    Todd PA; Brogden RN
    Drugs; 1989 Jun; 37(6):871-99. PubMed ID: 2503348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract]   [Full Text] [Related]  

  • 18. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster A; Pankhurst T; Rinaldi F; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004756. PubMed ID: 16625610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression following organ transplantation. Part 1: mechanisms and immunosuppressive agents.
    Cajanding R
    Br J Nurs; 2018 Sep; 27(16):920-927. PubMed ID: 30187798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction immunotherapy with IL-2Ra monoclonal antibody in kidney transplantation.
    Ahsan N
    Minerva Urol Nefrol; 2003 Mar; 55(1):67-79. PubMed ID: 12773968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.